Can Circulating Tumor DNA be Utilized as a Marker to Guide High-Risk Head and Neck Squamous Cell Patients Treatment?

• DOI: 10.1016/j.ijrobp.2024.01.078
• Publication Date: 2024-03-14T07:09:08Z
• Authors: M.D. Orland; M. Stewart; N. Rajaram Siva; T. Kuzmanovic; N. Karasik; S.R. Campbell; J.A. Miller; N.M. Woody; N. Silver; J. Ku; J. Scharpf; E. Lamarre; B. Prendes; T. Sussman; J.L. Geiger; E. Yilmaz
• Keywords: Squamous cell cancer